[go: up one dir, main page]

TR201007107A1 - Formulations of cefpodoxime proxetil containing taste regulating agent. - Google Patents

Formulations of cefpodoxime proxetil containing taste regulating agent.

Info

Publication number
TR201007107A1
TR201007107A1 TR2010/07107A TR201007107A TR201007107A1 TR 201007107 A1 TR201007107 A1 TR 201007107A1 TR 2010/07107 A TR2010/07107 A TR 2010/07107A TR 201007107 A TR201007107 A TR 201007107A TR 201007107 A1 TR201007107 A1 TR 201007107A1
Authority
TR
Turkey
Prior art keywords
formulations
regulating agent
cefpodoxime proxetil
containing taste
taste regulating
Prior art date
Application number
TR2010/07107A
Other languages
Turkish (tr)
Inventor
B�Lg�� Mahmut
Original Assignee
B�Lg�� Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B�Lg�� Mahmut filed Critical B�Lg�� Mahmut
Priority to TR2010/07107A priority Critical patent/TR201007107A1/en
Priority to PCT/TR2011/000201 priority patent/WO2012026908A2/en
Priority to EP11767093.5A priority patent/EP2663289A2/en
Publication of TR201007107A1 publication Critical patent/TR201007107A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, sefpodoksim proksetil içeren farmasötik formülasyonlara ilişkindir.The present invention relates to pharmaceutical formulations comprising cefpodoxime proxetil.

TR2010/07107A 2010-08-25 2010-08-25 Formulations of cefpodoxime proxetil containing taste regulating agent. TR201007107A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2010/07107A TR201007107A1 (en) 2010-08-25 2010-08-25 Formulations of cefpodoxime proxetil containing taste regulating agent.
PCT/TR2011/000201 WO2012026908A2 (en) 2010-08-25 2011-08-24 Cefpodoxime proxetil formulations comprising taste regulating agent
EP11767093.5A EP2663289A2 (en) 2010-08-25 2011-08-24 Cefpodoxime proxetil formulations comprising taste regulating agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/07107A TR201007107A1 (en) 2010-08-25 2010-08-25 Formulations of cefpodoxime proxetil containing taste regulating agent.

Publications (1)

Publication Number Publication Date
TR201007107A1 true TR201007107A1 (en) 2012-03-21

Family

ID=44764206

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/07107A TR201007107A1 (en) 2010-08-25 2010-08-25 Formulations of cefpodoxime proxetil containing taste regulating agent.

Country Status (3)

Country Link
EP (1) EP2663289A2 (en)
TR (1) TR201007107A1 (en)
WO (1) WO2012026908A2 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486425A (en) 1980-09-30 1984-12-04 Sankyo Company Limited 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates
DE60205870T2 (en) * 2001-02-27 2006-06-29 Ranbaxy Laboratories, Ltd. ORAL PHARMACEUTICAL COMPOSITION OF CEFPODOXIM PROXETIL
TW200404550A (en) * 2002-07-08 2004-04-01 Sankyo Co Cepharospolin formulation for oral use
EP1539146A1 (en) * 2002-07-16 2005-06-15 Ranbaxy Laboratories, Ltd. Dispersible tablets for oral administration
WO2007017895A2 (en) * 2005-05-05 2007-02-15 Lupin Limited Stabilized oral pharmaceutical compositions of cephalosporins
TR201002878A2 (en) * 2010-04-13 2011-10-21 Bi̇lgi̇ç Mahmut Pharmaceutical compositions comprising cefpodoxime proxetil.

Also Published As

Publication number Publication date
WO2012026908A3 (en) 2012-09-07
EP2663289A2 (en) 2013-11-20
WO2012026908A2 (en) 2012-03-01

Similar Documents

Publication Publication Date Title
JOP20180103A1 (en) Pharmaceutical composition
MD20150091A2 (en) Anti-viral compounds
MX2011008864A (en) Sulfonylated tetrahydroazolopyrazines and their use as medicinal products.
UA108101C2 (en) N3-substituted N1-sulfonyl-5-fluoropyrimidinone derivatives
IN2015DN03029A (en)
GEP20156318B (en) Heteroaryl derivatives as alpha7 nachr modulators
EA201270256A1 (en) DERIVATIVES OF T1-SUBSTITUTED 5-FLUOR-2-OXOPYRIMIDINON-1 (2H) -KARBOXAMID
PH12013501481A1 (en) Disialyllacto-n-tetraose (dslnt) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease
MX344846B (en) COMBINATION OF ACTIVE LOADED GRANULES WITH ADDITIONAL ASSETS.
MX340147B (en) PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS OF ABSCYSICAL ACID.
EA201500821A1 (en) Derivatives of 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purines, their use as pharmaceuticals and pharmaceutical compounds
WO2014086453A8 (en) Azaheterobicyclic compounds
GB201113880D0 (en) Novel compositions
IN2015DN02645A (en)
TR201007106A1 (en) Cefpodoxime proxetil formulations.
BR112013000941A2 (en) 14-epi-analog formulations of vitamin d
TR201002878A2 (en) Pharmaceutical compositions comprising cefpodoxime proxetil.
TR201009168A2 (en) Water dispersible cefpodoxime proxetil formulations.
IN2015DN02643A (en)
TR201007107A1 (en) Formulations of cefpodoxime proxetil containing taste regulating agent.
IN2015DN02646A (en)
TR201010859A2 (en) Tablet forms containing cefdinir.
EA201101703A1 (en) 17β-ALKYL-17α-OXYESTRATRIENES
IN2015DN02647A (en)
IN2014KN02584A (en)